article thumbnail

First CRISPR-based gene-editing therapy authorised

European Pharmaceutical Review

Side effects from treatment were similar to those associated with autologous stem cell transplants. No significant safety concerns were identified during the trials. Of these, 39 did not need a red blood cell transfusion for at least 12 months post-treatment.

Safety 92
article thumbnail

UK MHRA grants authorisation for Moderna’s Covid-19 booster vaccine

Pharmaceutical Technology

After the vaccine was found to meet the standards of safety and quality, the regulatory agency granted the authorisation. According to the safety monitoring, side effects were generally mild and self-resolving, as well as in line with those reported for the original Moderna booster dose. 1 Omicron variant of concern.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The internet enables misinformation on COVID

World of DTC Marketing

In some instances, vaccine-hesitant activists are manufacturing stories of deaths related to the vaccine that never happened. The major concerns for hesitancy included worries over side effects and that the vaccine is too new. Also cited was a lack of trust in the government to ensure the vaccines’ safety and effectiveness.

article thumbnail

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

However, disease heterogeneity has limited the field’s understanding of lupus, and the regulatory requirements for manufacturing and developing cell therapies have proven to be a hurdle. “[The] The CAR-T therapies for conditions like lupus continue to look promising, but their safety is a concern, says Gilkeson.

article thumbnail

Pharma coming to moral crossroads

World of DTC Marketing

” The speedy vaccine development protects pharma companies from litigation if patients get sick from nasty side effects but morally this is a serious question of judgment. government to manufacture 100 million doses of its investigational COVID-19 vaccine. J&J received more than $1 billion from the U.S.

article thumbnail

What GLP-1 drugs mean for medtech

Clarivate

GLP-1s will offer an attractive option to patients hesitant to undergo an invasive surgical procedure, and manufacturers like Medtronic and Johnson & Johnson anticipate a temporary dip in surgery volumes. Device-based treatments for comorbidities associated with obesity will also see an impact.

article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

While India and Italy are known for their active pharmaceutical ingredient (API) industries and production of generic drugs, other countries such as Brazil, Canada, South Korea, and others also have provisions for the manufacture and sale of generic drugs before the patent expires. of gross domestic product (GDP).